Methylation-associated silencing of heparan sulfate D-glucosaminyl 3-O-sulfotransferase-2 (3-OST-2) in human breast, colon, lung and pancreatic cancers

Oncogene

Volumn 22, Issue 2, 2003, Pages 274-280

  Miyamoto, Kazuaki ^a,c   Asada, Kiyoshi ^a   Fukutomi, Takashi ^b   Okochi, Eriko ^a   Yagi, Yukiko ^a   Hasegawa, Tadashi ^a   Asahara, Toshimasa ^c   Sugimura, Takashi ^a   Ushijima, Toshikazu ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b NATIONAL CANCER CENTER HOSPITAL   (Japan)

^c HIROSHIMA UNIVERSITY   (Japan)

Author keywords

3 OST 2; Breast cancer; DNA methylation; Silencing

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; HEPARAN SULFATE DEXTRO GLUCOSAMINYL 3 O SULFOTRANSFERASE 2; PROTEOHEPARAN SULFATE; SULFOTRANSFERASE; UNCLASSIFIED DRUG;

3 OST 2 GENE; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER GENETICS; CARBOHYDRATE ANALYSIS; COLON CANCER; CPG ISLAND; DEMETHYLATION; DNA METHYLATION; GENE; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG CANCER; NUCLEOTIDE SEQUENCE; PANCREAS CANCER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

BREAST NEOPLASMS; COLONIC NEOPLASMS; CPG ISLANDS; DNA METHYLATION; EXONS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; LUNG NEOPLASMS; MOLECULAR BIOLOGY; PANCREATIC NEOPLASMS; SULFOTRANSFERASES; TUMOR CELLS, CULTURED;

EID: 0037448688     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206146     Document Type: Article

References (35)

1. Asada K, Miyamoto K, Fukutomi T, Tsuda H, Yagi Y, Wakazono K, Oishi S, Fukui H, Sugimura T and Ushijima T. Oncology (in press).
2. Baylin SB, Esteller M, Rountree MR, Bachman KE, Schuebel K and Herman JG. (2001). Hum. Mol. Genet., 10, 687-692.
3. Bernfield M, Gotte M, Park PW, Reizes O, Fitzgerald ML, Lincecum J and Zako M. (1999). Annu. Rev. Biochem., 68, 729-777.
4. Bird A. (2002). Genes Dev., 16, 6-21.
5. Clark SJ, Harrison J, Paul CL and Frommer M. (1994). Nucleic Acids Res., 22, 2990-2997.
6. Clark SJ and Melki J. (2002). Oncogene, 21, 5380-5387.
7. Eads CA, Danenberg KD, Kawakami K, Saltz LB, Blake C, Shibata D, Danenberg PV and Laird PW. (2000). Nucleic Acids Res., 28, E32.
8. Esko JD and Lindahl U. (2001). J. Clin. Invest., 108, 169-173.
9. Esteller M, Corn PG, Baylin SB and Herman JG. (2001). Cancer Res., 61, 3225-3229.
10. Esteller M, Sanchez-Cespedes M, Rosell R, Sidransky D, Baylin SB and Herman JG. (1999). Cancer Res., 59, 67-70.
11. Feinberg AP. (2001). Nat. Genet., 27, 9-10.
12. Gardiner-Garden M and Frommer M. (1987). J. Mol. Biol., 196, 261-282.
13. Gonzalgo ML, Hayashida T, Bender CM, Pao MM, Tsai YC, Gonzales FA, Nguyen HD, Nguyen TT and Jones PA. (1998). Cancer Res., 58, 1245-1252.
14. Herman JG, Graff JR, Myohanen S, Nelkin BD and Baylin SB. (1996). Proc. Natl. Acad. Sci. USA., 93, 9821-9826.
15. Jones PA. (1999). Trends Genet., 15, 34-37.
16. Jones PA and Baylin SB. (2002). Nat. Rev. Genet., 3, 415-428.
17. Jones PA and Laird PW. (1999). Nat. Genet., 21, 163-167.
18. Kaneda A, Kaminishi M, Nakanishi Y, Sugimura T and Ushijima T. (2002). Int. J. Cancer, 100, 57-62.
19. Kaneda A, Kaminishi M, Yanagihara K, Sugimura T and Ushijima T. Cancer Res. (in press).
20. Kawakami K, Brabender J, Lord RV, Groshen S, Greenwald BD, Krasna MJ, Yin J, Fleisher AS, Abraham JM, Beer DG, Sidransky D, Huss HT, Demeester TR, Eads C, Laird PW, Ilson DH, Kelsen DP, Harpole D, Moore MB, Danenberg KD, Danenberg PV and Meltzer SJ. (2000). J. Natl. Cancer Inst., 92, 1805-1811.
21. Kelsey G, Bodle D, Miller HJ, Beechey CV, Coombes C, Peters J and Williamson CM. (1999). Genomics, 62, 129-138.
22. Lisitsyn N, Lisitsyn N and Wigler M. (1993). Science, 259, 946-951.
23. Matsuda K, Maruyama H, Guo F, Kleeff J, Itakura J, Matsumoto Y, Lander AD and Korc M. (2001). Cancer Res., 61, 5562-5569.
24. Muller K, Heller H and Doerfler W. (2001). J. Biol. Chem., 276, 14271-14278.
25. Perrimon N and Bernfield M. (2000). Nature, 404, 725-728.
26. Rein T, Zorbas H and DePamphilis ML. (1997). Mol. Cell. Biol., 17, 416-426.
27. Sambrook J, Fritsch EF and Maniatis T. (eds). (1989). Molecular Cloning, Vol. 2. Cold Spring Harbor Laboratory Press: Cold Spring Harbor, New York, pp 1914-1923.
28. Shapiro B, Chakrabarty M, Cohn EM and Leon SA. (1983). Cancer, 51, 2116-2120.
29. Shworak NW, Liu J, Petros LM, Zhang L, Kobayashi M, Copeland NG, Jenkins NA and Rosenberg RD. (1999). J. Biol. Chem., 274, 5170-5184.
30. Silva JM, Dominguez G, Villanueva MJ, Gonzalez R, Garcia JM, Corbacho C, Provencio M, Espana P and Bonilla F. (1999). Br. J. Cancer, 80, 1262-1264.
31. Stanley MJ, Stanley MW, Sanderson RD and Zera R. (1999). Am. J. Clin. Pathol., 112, 377-383.
32. Stroun M, Anker P, Maurice P, Lyautey J, Lederrey C and Beljanski M. (1989). Oncology, 46, 318-322.
33. Surani MA. (2001). Nature, 414, 122-128.
34. Takai D, Yagi Y, Wakazono K, Ohishi N, Morita Y, Sugimura T and Ushijima T. (2001). Oncogene, 20, 7 505-7513.
35. Ushijima T, Morimura K, Hosoya Y, Okonogi H, Tatematsu M, Sugimura T and Nagao M. (1997). Proc. Natl. Acad. Sci. USA., 94, 2284-2289.